Trial Profile
Phase II Evaluation of Temodal (Temozolomide, Schering) in Previously Treated Advanced Sarcomas
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Jun 2015
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Sarcoma
- Focus Therapeutic Use
- 10 Sep 2005 New trial record.